• Users Online: 39855
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model
Mehmet Tuzcu,Cemal Orhan,Omer Ersin Muz,Nurhan Sahin,Vijaya Juturu,Kazim Sahin
BMC Ophthalmology.2017;17(1)
[DOI]
2Interactive retinal blood flow estimation from fluorescein angiograms
Rubiel Vargas Cañas,Panos Liatsis
Proceedings of the Institution of Mechanical Engineers, Part C: Journal of Mechanical Engineering Science.2012;226(10)2521
[DOI]
3Bevacizumab for eye diseases – Legal, regulatory, and ethical overview
Vinu Jose,Swetha Radhakrishna,Parag Pipalava,Inderjeet Singh
Indian Journal of Pharmacology.2019;51(6)377
[DOI]
4Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab
Patricia Muñoz-Villegas,Alejandra Sanchez-Rios,Mayra G Quinonez-Alvarado,Oscar Olvera-Montaño,Juan D Quintana-Hau,Leopoldo Baiza-Duran
Journal of Experimental Pharmacology.2021;Volume 13(6)545
[DOI]
5Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Jose Navarro-Partida,Juan Carlos Altamirano-Vallejo,Luis Abraham Aceves Franco,Jesús Gonzalez-Cortes,Sergio Hernandez-Da Mota,Jose Gerardo García-Aguirre,Carlos David Azuara-Galindo,Carlos Rodrigo Castro-Castaneda,Juan Armendariz-Borunda,Arturo Santos
Pharmaceutics.2021;13(9)1491
[DOI]
6Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Weng Onn Chan,Jagjit S. Gilhotra
Pharmaceutics.2019;13(9)159
[DOI]
7Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
Bassey Fiebai,Victor Odogu
The Open Ophthalmology Journal.2017;11(1)315
[DOI]
8Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review
Soumya Narayana,Mohammed Gulzar Ahmed,B. H. Jaswanth Gowda,Pallavi K. Shetty,Arfa Nasrine,M. Thriveni,Nadira Noushida,A. Sanjana
Future Journal of Pharmaceutical Sciences.2021;7(1)315
[DOI]
9New Biomarker for Neovascular Age-Related Macular Degeneration: Eotaxin-2
Neel Kamal Sharma,Sudesh Prabhakar,Amod Gupta,Ramandeep Singh,Pawan Kumar Gupta,Pramod Kumar Gupta,Akshay Anand
DNA and Cell Biology.2012;31(11)1618
[DOI]
10Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration
Focke Ziemssen,Salvatore Grisanti,Karl Ulrich Bartz-Schmidt,Martin S. Spitzer
Drugs & Aging.2009;26(4)295
[DOI]
11Therapies Based on Nanoparticles for Eye Drug Delivery
Alejandra Meza-Rios,Jose Navarro-Partida,Juan Armendariz-Borunda,Arturo Santos
Ophthalmology and Therapy.2020;9(3)1
[DOI]
12Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema
Jose Navarro-Partida,Juan Carlos Altamirano-Vallejo,Alejandro Gonzalez-De la Rosa,Juan Armendariz-Borunda,Carlos Rodrigo Castro-Castaneda,Arturo Santos
Pharmaceutics.2021;13(3)322
[DOI]
13Back to basics: aged-related macular degeneration
Elizabeth Kerr
Nursing and Residential Care.2013;15(7)484
[DOI]
14Prevalence of age-related macular degeneration and associated factors in Indian cohort in a tertiary care setting
Jacqueline Hamati,Sai Prashanthi,Raja Narayanan,Niroj Sahoo,Anthony Vipin Das,Padmaja Kumari Rani,Umesh Chandra Behera,Rohit Khanna,Gudlavalleti V S Murthy
Indian Journal of Ophthalmology.2023;71(10)3361
[DOI]
15Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study
Jose Navarro-Partida,Juan Carlos Altamirano-Vallejo,Edgar Jose Lopez-Naranjo,Alejandro Gonzalez-De la Rosa,Alejandro Manzano-Ramírez,Luis Miguel Apatiga-Castro,Juan Armendáriz-Borunda,Arturo Santos
Journal of Ocular Pharmacology and Therapeutics.2020;36(6)393
[DOI]
16Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
Subhasish Pramanik,Lakshmi Kanta Mondal,Suman Kalyan Paine,Sneha Jain,Subhankar Chowdhury,Upasana Ganguly,Sayantan Ghosh,Chiranjit Bose,Koena Bhattacharjee,Gautam Bhaduri
Clinical Ophthalmology.2021;Volume 15(6)3341
[DOI]
17Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
Arturo Santos,Juan C. Altamirano-Vallejo,José Navarro-Partida,Alejandro González-De la Rosa,Jane H. Hsiao
Clinical Ophthalmology.2020;Volume 15(6)3341
[DOI]
18Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis?
Akshay Anand,Neel K. Sharma,Ramandeep Singh,Amod Gupta,Sudesh Prabhakar,Neeru Jindal,Arvind K. Bhatt,Suresh K. Sharma,Pawan K. Gupta
Scientific Reports.2014;4(1)3341
[DOI]
19VERTEPORFIN COMBINATION REGIMENS IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
GAURAV K. SHAH,DELIA N. SANG,MARK S. HUGHES
Retina.2009;29(2)133
[DOI]
20Effects of core vitrectomy in the treatment of age-related macular degeneration
Katharina Schramm,Michael Mueller,Frank H. Koch,Pankaj Singh,Thomas Kohnen,Michael J. Koss
Acta Ophthalmologica.2014;92(5)465
[DOI]
21Age-related macular degeneration: a case study
Elizabeth Kerr
British Journal of Nursing.2010;19(11)693
[DOI]
22Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab
Taraprasad Das,Srinivas Volety,Saad M Ahsan,Abhay K Thakur,Savitri Sharma,Tapas R Padhi,Soumyava Basu,Ch Mohan Rao
Clinical & Experimental Ophthalmology.2015;43(5)466
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal